Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$396M |
| 2 |
JPMorgan Chase
JPM
|
+$167M |
| 3 |
Extra Space Storage
EXR
|
+$148M |
| 4 |
GE HealthCare
GEHC
|
+$120M |
| 5 |
Patterson-UTI
PTEN
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PDCE
PDC Energy, Inc.
PDCE
|
+$313M |
| 2 |
Super Micro Computer
SMCI
|
+$310M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$176M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$160M |
| 5 |
Walmart Inc
WMT
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.29% |
| 2 | Financials | 16.14% |
| 3 | Industrials | 13.23% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSXY
2326
Victoria's Secret
VSXY
$7.09B
| $8.81M | ﹤0.01% |
527,951
-150,392
| -22% | -$2.84M |
|
2327
Ultralife
ULBI
$88.3M
| $8.78M | ﹤0.01% |
899,836
-19,839
| -2% | -$159K |
|
2328
inTEST
INTT
$143M
| $8.77M | ﹤0.01% |
578,439
+7,847
| +1% | +$145K |
|
|
CWEN.A
2329
DELISTED
Clearway Energy Class A
CWEN.A
| $8.73M | ﹤0.01% |
438,486
+1,274
| +0.3% | +$30.5K |
|
2330
Ionis Pharmaceuticals
IONS
$8.93B
| $8.72M | ﹤0.01% |
192,160
+9,446
| +5% | +$390K |
|
2331
Vera Bradley
VRA
$98.7M
| $8.71M | ﹤0.01% |
1,317,090
-69,789
| -5% | -$463K |
|
2332
Flexsteel Industries
FLXS
$307M
| $8.66M | ﹤0.01% |
417,377
-14,907
| -3% | -$305K |
|
|
BAND
2333
Bandwidth Inc
BAND
$1.19B
| $8.63M | ﹤0.01% |
765,578
+109,967
| +17% | +$1.5M |
|
2334
Lakeland Industries
LAKE
$108M
| $8.63M | ﹤0.01% |
572,466
-2,046
| -0.4% | -$30.3K |
|
|
BPMC
2335
DELISTED
Blueprint Medicines
BPMC
| $8.62M | ﹤0.01% |
171,663
-112,307
| -40% | -$6M |
|
2336
Evolution Petroleum
EPM
$133M
| $8.59M | ﹤0.01% |
1,255,277
+30,891
| +3% | +$261K |
|
2337
Amtech Systems
ASYS
$239M
| $8.59M | ﹤0.01% |
1,126,731
-13,605
| -1% | -$124K |
|
2338
Relay Therapeutics
RLAY
$4B
| $8.56M | ﹤0.01% |
1,017,668
-146,718
| -13% | -$1.58M |
|
2339
4D Molecular Therapeutics
FDMT
$502M
| $8.54M | ﹤0.01% |
670,599
+239,488
| +56% | +$4.01M |
|
2340
Concrete Pumping Holdings
BBCP
$491M
| $8.49M | ﹤0.01% |
989,820
+90,466
| +10% | +$729K |
|
2341
Forum Energy Technologies
FET
$578M
| $8.49M | ﹤0.01% |
353,350
+25,164
| +8% | +$628K |
|
2342
AdaptHealth
AHCO
$1.47B
| $8.46M | ﹤0.01% |
929,920
+525,680
| +130% | +$6.3M |
|
|
NETI
2343
DELISTED
Eneti Inc.
NETI
| $8.46M | ﹤0.01% |
838,791
+159,224
| +23% | +$1.83M |
|
2344
Dyne Therapeutics
DYN
$4.68B
| $8.45M | ﹤0.01% |
943,208
+142,983
| +18% | +$1.54M |
|
|
SMMF
2345
DELISTED
Summit Financial Group, Inc.
SMMF
| $8.45M | ﹤0.01% |
374,861
+32,131
| +9% | +$741K |
|
2346
AerSale
ASLE
$291M
| $8.44M | ﹤0.01% |
564,710
+258,175
| +84% | +$3.72M |
|
|
MTTR
2347
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $8.41M | ﹤0.01% |
3,877,928
+2,225,531
| +135% | +$6.24M |
|
2348
Limoneira
LMNR
$244M
| $8.39M | ﹤0.01% |
547,687
-75,379
| -12% | -$1.15M |
|
2349
GoodRx Holdings
GDRX
$1.09B
| $8.36M | ﹤0.01% |
1,485,454
+258,187
| +21% | +$1.72M |
|
2350
Amneal Pharmaceuticals
AMRX
$6.1B
| $8.34M | ﹤0.01% |
1,974,812
+776,702
| +65% | +$2.9M |
|
Similar funds
Dimensional Fund Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Dimensional Fund Advisors held 3,560 positions worth $305B, down 2.8% from $314B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.9%. Dimensional Fund Advisors opened 80 new positions and exited 93, leaving the 3,560-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2023 buy was Kenvue: 17,128,393 shares worth $344M.
- Dimensional Fund Advisors added most to JPMorgan Chase in Q3 2023, an estimated $167M increase.
- Dimensional Fund Advisors's biggest Q3 2023 reduction was Super Micro Computer, cutting an estimated $310M.
- Dimensional Fund Advisors fully exited PDC Energy, Inc. in Q3 2023, selling an estimated $313M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $305B portfolio in Q3 2023.
- Dimensional Fund Advisors opened 80 new positions and closed 93 in Q3 2023.
- Dimensional Fund Advisors's portfolio value fell 2.8% quarter-over-quarter to $305B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.